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Background: Initial fluid resuscitation is an important hemodynamic therapy in patients with septic shock. The
Surviving Sepsis Campaign Guidelines recommend fluid resuscitation with volume loading according to central
venous pressure (CVP). However, patients with septic shock often develop a transient decrease in cardiac function;
thus, it may be inappropriate to use CVP as a reliable marker for fluid management.
Methods: We evaluated 40 adult patients with septic shock secondary to intra-abdominal infection who received
active treatment and were monitored using transthoracic echocardiography (TTE) and CVP for 2 days after admission
to our intensive care unit (ICU). We measured left ventricular end-diastolic diameter (LVEDD), left atrial diameter (LAD),
and the pressure gradient of tricuspid regurgitation (TRΔP). The shock status was treated with volume loading and
inotrope/vasopressor administration according to the TTE findings. We assessed left ventricular fractional shortening
(LVFS) as an index of left ventricular contractility and TRΔP as an index of right ventricular afterload and then examined
the correlation between CVP and LVEDD/LAD/TRΔP.
Results: LVFS decreased to ≤30% in 42.5% and 27.5% of patients with septic shock, and severe left ventricular
dysfunction with LVFS ≤20% developed in 12.5% and 15.0% of patients on the first and second ICU days, respectively,
despite the use of inotropes/vasopressors. Mild pulmonary hypertension as indicated by TRΔP ≥30 mmHg was present
in 27.5% and 30.0% of patients on their first and second ICU days, respectively. There was no significant correlation
between CVP and LVEDD/LAD/TRΔP. The hospital mortality rate in this study was 10.0%, although the predicted
mortality based on the Acute Physiology and Chronic Health Evaluation II score was 58.7%.
Conclusions: Our results suggest that CVP is not a reliable marker of left ventricular preload for fluid management
during the initial phase of septic shock. Assessment of left ventricular preload, right ventricular overload, and left
ventricular contractility using TTE seems to be more informative than the measurement of CVP for fluid resuscitation
since some patients developed left ventricular dysfunction and/or right ventricular overload.
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Initial fluid resuscitation is an important hemodynamic
therapy for patients with septic shock. The Surviving
Sepsis Campaign Guidelines (SSCG) recommend the use
of central venous pressure (CVP) as a marker of intra-
vascular volume status [1]. Therefore, CVP has been
traditionally used to assess fluid status; however, its value
as a tool for guiding fluid resuscitation has been debated
[2]. Patients with severe sepsis/septic shock often exhibit
transient cardiovascular dysfunction [3]; thus, it may be
inappropriate to use CVP as a reliable marker for fluid
management. In addition, CVP, which is the pressure re-
corded in the superior/inferior vena cava near the right
atrium, does not appear to be associated with intravas-
cular volume or left ventricular preload. To investigate
whether CVP is a reliable marker of left ventricular
preload for fluid resuscitation in patients with septic
shock, we assessed cardiac function using transthoracic
echocardiography (TTE) and investigated the association
of CVP with left ventricular end-diastolic diameter
(LVEDD), left atrial diameter (LAD), and the pressure
gradient of tricuspid regurgitation (TRΔP).
Methods
This retrospective study was approved by The Okayama
Red Cross Hospital Ethics Committee.
All adult patients with septic shock secondary to intra-
abdominal infection who were admitted to the intensive
care unit (ICU) between April 2006 and March 2012
were included in this study. Among them, patients who
received active treatment, such as surgical removal of
the source of infection, and who were monitored using
TTE and CVP for 2 days after ICU admission were
selected for analysis. We excluded patients who did not
require norepinephrine support, lacked data of TTE
monitoring on the first or second ICU day, developed
septic shock after elective surgery, stayed in ICU <48 h,
or had terminal cancer.
We measured LVEDD, left ventricular end-systolic
diameter (LVESD), LAD, and TRΔP. Left ventricular
fractional shortening (LVFS) was calculated by dividing
the differences between LVEDD and LVESD by LVEDD.
We aimed to keep the mean arterial pressure at ≥80
mmHg and the urine output at ≥1 mL/kg/h. For fluid
resuscitation, we aimed to maintain an intravascular
volume with LVEDD 40–50 mm, LAD 25–35 mm, and
TRΔP ≤30 mmHg, as evaluated by TTE. We used the
following inotropes/vasopressors and diuretics: dopa-
mine, ≤10 μg/kg/min; norepinephrine, ≤0.5 μg/kg/min;
vasopressin, ≤0.017 U/min (1 U/h); furosemide, ≤10 mg/h;
and carperitide, ≤0.69 μg/min (1,000 μg/day).
We assessed LVFS as an index of left ventricular
contractility and TRΔP as an index of right ventricular
afterload and then examined the correlation betweenCVP and LVEDD/LAD/TRΔP. Data of fluid intake, net
output, and calculated fluid balance during the first 48 h
were collected.Statistical analysis
Data are expressed as mean ± standard deviation or
median (Q1–Q3; interquartile range). Statistical analysis
was performed using Excel 2011 (Microsoft USA) with
the add-in software Statcel 3 [4]. Data were analyzed
using Pearson’s correlation coefficient or Spearman’s
correlation coefficient by rank test depending on the
distribution pattern. The median (95% confidence interval,
CI) values of FS and TRΔP were analyzed by Wilcoxon’s
signed-rank test. A P value of less than 0.05 was consid-
ered statistically significant.Results
The number of adult patients with septic shock second-
ary to intra-abdominal infection during the study term
was 124. Among these, 40 patients (19 men and 21
women; mean age, 76.1 ± 10.4 years) were deemed eli-
gible for participation in this study and were included in
the final analysis (Figure 1). The most common source
of sepsis was perforation of the lower digestive tract
(Table 1). Thirteen patients had preexisting heart disease
and five had preexisting respiratory disease (Table 2).
LVFS decreased to ≤30% in 17 (42.5%) and 11 (27.5%)
patients on the first and second ICU days, and severe
left ventricular dysfunction with LVFS ≤20% occurred in
five (12.5%) and six (15.0%) patients on the first and
second ICU days, respectively, despite the use of inotropes/
vasopressors (Figure 2), and mild pulmonary hypertension
with TRΔP ≥30 mmHg occurred in 11 (27.5%) and 12
(30.0%) patients on the first and second ICU days, respect-
ively (Figure 3). There was no correlation between CVP
and LVEDD on the first and second ICU days (correlation
coefficients, 0.01 and −0.09, respectively; Figure 4). As
shown in Figures 5 and 6, there were no correlations be-
tween CVP and LAD or TRΔP with correlation coefficients
of 0.04 and 0.19 on the first ICU day and 0.06 and 0.01 on
the second ICU day, respectively.
The median doses of intravenous fluid intake during the
first and second 24-h periods were 5,216 (4,311–6,618)
mL and 2,927 (2,480–3,566) mL, whereas net outputs
were 3,280 (2,445–4,540) mL and 3,156 (2,510–4,040) mL,
and fluid balances were 2,455 (1,051–3,528) mL and −71
(−853–287) mL, respectively.
The mean Acute Physiology and Chronic Health
Evaluation (APACHE) II score was 24.9 ± 6.6. The ICU
mortality rate was 2.5% (one patient) and the 28-day
mortality rate was 5.0% (two patients). The in-hospital
mortality rate was 10.0% (four patients), which was less
than the predicted rate of 58.7% calculated from the
124 patients were admitted to the ICU
with septic shock due to
intra-abdominal infection
83 patients who received active treatment and were monitored  using 
TTE and CVP on the 1st day and 2nd day after ICU admission
40 patients were eligible for this study
41 patients were excluded
11: had no norepinephrine support
13: lacked data of TTE monitoring  on the 1st day  or  2nd day
6: developed after elective surgery
8: stayed in ICU  <48 h
3: had terminal cancer 
43 patients were excluded because of 
missing TTE monitoring data 
Figure 1 Screening of study patients.
Table 2 Preexisting cardiopulmonary complications of 40
patients
Preexisting disease of 40 patients Number of patients
Heart disease 13 (33%)a
Ischemic heart disease 6
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days. Three patients required blood purification.
Discussion
We used TTE to investigate whether CVP could be a useful
guide for the assessment of left ventricular preload and
volume status in the early phase of septic shock. Our results
showed there was no association between CVP and
LVEDD/LAD/TRΔP, suggesting that CVP is an inappropri-
ate marker of left ventricular preload for fluid resuscitation.
CVP is currently the most practical target for fluid
resuscitation and may be used to gauge fluid balance ≤12 h
into septic shock, but it becomes unreliable as a marker of
fluid balance thereafter [5]. Previous reports have suggested
that CVP-guided fluid resuscitation may be inappropriate
for septic shock [6-8]. In a systematic review by Marik et al.
[6], they examined the relationship between intravascular
volume and CVP in patients with sepsis and postoperative
patients and determined the correlation coefficient of CVPTable 1 Source of sepsis of 40 patients
Source of sepsis Number of patients
Lower digestive tract perforation 13 (32.5%)
Liver/biliary tract disease 9 (22.5%)
Urinary tract infection 8 (20%)
Colitis 4 (10%)
Upper gastrointestinal tract perforation 3 (7.5%)
Ileus 2 (5%)
Non-obstructive intestinal ischemia 1 (2.5%)with intravascular volume of 0.16, and the correlation
coefficient of baseline CVP with a change in cardiac
index was 0.18 and the area under the receiver operat-
ing characteristic curve was 0.56, indicating a poor
correlation. Furthermore, a subsequent review reported
similar results. The correlation coefficient between the
baseline CVP and the change in cardiac index was 0.18
(95% CI, 0.1–0.25); therefore, these data do not supportPulmonary hypertension 2
Dilated cardiomyopathy 1
Sick sinus syndrome 1
Tricuspid regurgitation 1














































Median 35.0 (27.3–42.0) Median 35.7 (29.0–42.0)
Figure 2 Left ventricular fractional shortening in patients with septic shock. Left ventricular fractional shortening decreased to ≤30% in
42.5% and 27.5%, and to ≤20% in 12.5% and 15.0% of patients on the first and second intensive care unit (ICU) days, respectively. There was no
significant difference (P = 0.72) in median value between the first and second ICU days.
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http://www.jintensivecare.com/content/2/1/58the widespread practice of using CVP as a guide for fluid
therapy [7]. In addition, a study of healthy subjects deter-
mined that CVP was not useful to predict response to
volume load because it did not reflect the ventricular













































Figure 3 Pressure gradient of tricuspid regurgitation in patients with
of tricuspid regurgitation of ≥30 mmHg occurred in 27.5% and 30.0% on t
was no significant difference (P =0.17) in median value between the first anIn the early stages of sepsis, a high cardiac output
(hyperdynamic) state was conventionally considered to
be present; however, left ventricular contractility has been
reported to be decreased following increased cardiac out-
put. In the present study, left ventricular contractility wasMedian 25.0 (21.0–30.0) 
     Intensive Care Unit Day 2  
septic shock. Mild pulmonary hypertension with a pressure gradient
he first and second intensive care unit (ICU) days, respectively. There
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Left Ventricular End-Diastolic Diameter (mm)
Intensive Care Unit Day 2
r=-0.09P=0.58
Figure 4 Central venous pressure versus left ventricular end-diastolic diameter in patients with septic shock. There was no significant
correlation between central venous pressure and left ventricular end-diastolic diameter on the first and second intensive care unit days.
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left ventricular dysfunction (LVFS ≤20%) occurred in
13% and 15% of patients, and left ventricular dysfunc-
tion (LVFS ≤30%) was evident in 43% and 28%, respect-
ively, despite the use of inotropes/vasopressors. Pulido
et al. [9] reported the presence of myocardial dysfunction
in 64% of patients with severe sepsis/septic shock within 24
h of ICU admission, with left ventricular systolic dysfunc-
tion and diastolic dysfunction present in 27% and 37% of
patients, respectively.
With regard to right ventricular afterload, 28% of
patients in this study presented with moderate pulmonary
hypertension, with TRΔP ≥30 mmHg on the day of ICU
admission. Right ventricular dysfunction also occurs in
some patients without preexisting pulmonary hyperten-
sion [2]. Pulido et al. [9] described right heart failure in
31% of patients within 24 h of ICU admission. Baron et al.
[10] also reported right heart failure in a case of septic
cardiomyopathy. The SSCG indicate that CVP should not
be used as a marker of intravascular volume status in
patients with preexisting pulmonary hypertension.
The policy of early fluid resuscitation and inotrope/vaso-
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Figure 5 Central venous pressure versus left atrial diameter in patien
central venous pressure and left atrial diameter on the first and second intepatients with septic shock. Fluid overload may trigger heart
failure, potentially causing cardiac depression, especially in
patients with septic cardiomyopathy. Extreme volume load-
ing is associated with an increased risk of mortality [5]. In
our series, four patients showed LVEDD ≥50 mm despite
CVP ≤8 mmHg. In such patients, CVP-guided volume
loading may cause heart failure. Actually, the infusion
volume of these four patients was less than that of the
others included in this study. Furthermore, the infusion
volume in ICU is generally less than that reported by Boyd
et al. [5]. Therefore, evaluation of cardiac function is
important to guide fluid management in patients with
septic shock. CVP is an unsuitable index in this regard.
So, we usually evaluate left ventricular preload, right
ventricular afterload, and left ventricular contractility
using TTE and regulate volume loading with inotrope/
vasopressor administration on the basis of the TTE
findings instead of CVP.
TTE is a versatile, accurate, and noninvasive tool suitable
for bedside examinations of patients with septic shock and
has become a widely used hemodynamic-monitoring
technique in ICU [11]. However, evaluation using echocar-
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ts with septic shock. There was no significant correlation between
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Pressure Gradient of Tricuspid Regurgitation (mmHg)
Intensive Care Unit Day 2
r=0.01 P=0.97
Figure 6 Central venous pressure versus the pressure gradient of tricuspid regurgitation in patients with septic shock. There was no
significant correlation between central venous pressure and the pressure gradient of tricuspid regurgitation on the first and second intensive care
unit days.
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difficult. Accurate assessment of cardiac function and
intravascular volume is possible by performing frequent
measurements. We performed TTE frequently until the
patient hemodynamics stabilized. Recently, various dynamic
parameters (e.g., stroke volume variation, pulse pressure
variation, global end-diastolic volume, and intrathoracic
blood volume) have been proposed for the evaluation of
fluid therapy and hemodynamics in patients with septic
shock [12]. However, many of these parameters require
dedicated equipment, whereas TTE does not require a
special device.
Among our patients, the mean APACHE II score was
24.9 and the in-hospital mortality rate was 10.0%, which
was much lower than the predicted rate of 58.7% calculated
from the APACHE II scores. These results support the
utility of TTE.
There are some limitations to this study that should
be addressed. First, the study design was retrospective
and thereby potentially subject to systematic error and
bias, and the sample size was relatively small because of
exclusion of cases with missing values. In addition, we
were unable to fix specific time points for sampling; and
therefore, these data may not be as precise as they could
be. Hence, our results concern only the initial phase of
septic shock. Second, there was no control group in
which only CVP was used. Therefore, we were unable to
definitely conclude that TTE is superior to CVP. Thus,
further prospective studies with a control group in
which only CVP was used are required to show the
superiority of TTE. However, an assessment of the left
ventricular preload, right ventricular overload, and left
ventricular contractility using TTE was informative for
fluid resuscitation. Third, we used different target values
(mean arterial pressure and urine output) than those
recommended by SSCG. This might have affected the
outcome. We used a higher target mean arterial pressure
because the patients admitted to our hospital with septicshock were often elderly and many had hypertension.
Advanced age and chronic hypertension cause a rightward
shift of the curve for organ pressure-flow autoregulation;
and therefore, an increase in the mean arterial pressure
could result in improved organ perfusion. Regarding the
urine flow target, we used different criteria because the
administration of transfusion or antimicrobial agents
becomes difficult if the urine output is not maintained.
Thus, we attempted to maintain the urine output in order
to keep the treatment as conservative as possible.Conclusions
Our results showed that there was no correlation between
the CVP and TTE findings in patients with septic shock.
Therefore, CVP may not be a reliable marker of left
ventricular preload for fluid management during the initial
phase of septic shock. We observed that the assessment of
left ventricular preload, right ventricular afterload, and left
ventricular contractility using TTE is more informative
than the measurement of CVP during initial fluid resusci-
tation in patients with septic shock, because patients with
severe sepsis/septic shock often develop cardiovascular
dysfunction.Availability of supporting data
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